← Back to Screener
YD Bio Limited Ordinary Shares (YDES)
Price$3.01
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-81.82%
Price vs S&P 500 (4W)-43.30%
VGM Score14.59
Market Capitalization$255.70M
All Metrics
Book Value / Share (Quarterly)$0.07
P/TBV (Annual)9.30x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.11
Price vs S&P 500 (YTD)-83.47%
EPS (TTM)$-1.14
10-Day Avg Trading Volume0.02M
EPS Excl Extra (TTM)$-1.14
EPS (Annual)$-0.12
ROI (Annual)-21.30%
Gross Margin (Annual)28.05%
Cash / Share (Quarterly)$0.09
ROA (Last FY)-60.32%
EBITD / Share (TTM)$-0.16
Cash Flow / Share (Annual)$-0.11
P/B Ratio50.25x
P/B Ratio (Quarterly)8.39x
Net Income / Employee (Annual)$-1,662,300
Net Interest Coverage (TTM)10.54x
ROA (TTM)-176.28%
EPS Incl Extra (Annual)$-0.12
Current Ratio (Annual)5.88x
Quick Ratio (Quarterly)4.11x
3-Month Avg Trading Volume0.02M
Tangible BV / Share (Quarterly)$0.03
P/S Ratio (Annual)428.44x
Asset Turnover (Annual)0.04x
52-Week High$25.00
EPS Excl Extra (Annual)$-0.12
26-Week Price Return-73.89%
Quick Ratio (Annual)4.11x
13-Week Price Return-64.07%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)5.88x
Enterprise Value$249.69M
Revenue / Employee (Annual)$119,400
Inventory Turnover (Annual)0.45x
Pretax Margin (Annual)-1392.86%
Cash / Share (Annual)$0.09
3-Month Return Std Dev102.43%
Net Income / Employee (TTM)$-2,719,100
ROE (Last FY)-21.42%
EPS Basic Excl Extra (Annual)$-0.12
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-1.14
Receivables Turnover (Annual)2.12x
Revenue / Share (Annual)$0.01
Tangible BV / Share (Annual)$0.06
Year-to-Date Return-75.31%
5-Day Price Return-1.79%
EPS Normalized (Annual)$-0.12
Net Profit Margin (Annual)-1392.60%
Month-to-Date Return-6.52%
EBITD / Share (Annual)$-0.08
Operating Margin (Annual)-883.30%
LT Debt / Equity (Annual)0.00x
EPS Basic Excl Extra (TTM)$-1.14
P/TBV (Quarterly)19.53x
P/B Ratio (Annual)5.52x
Inventory Turnover (TTM)0.59x
Book Value / Share (Annual)$0.09
Price vs S&P 500 (13W)-72.33%
Beta-0.24x
52-Week Low$2.88
mGradeF
vgmGradeF
Show chart for
Industry Peers — Health Services(28)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
YDESYD Bio Limited Ordinary Shares | — | — | F | $3.01 |
| NTRANatera, Inc. Common Stock | F | A | C | $215.31 |
| DGXQuest Diagnostics Inc. | C | D | C | $200.29 |
| LHLabcorp Holdings Inc. | C | D | C | $265.15 |
| EXASExact Sciences Corp | F | B | B | $0.00 |
| GHGuardant Health, Inc. Common Stock | F | A | B | $125.61 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | D | $16.49 |
| CELCCelcuity Inc. Common Stock | — | — | C | $88.28 |
| RDNTRadNet, Inc. Common Stock | D | C | C | $54.34 |
| VCYTVeracyte, Inc. | D | A | B | $48.73 |
| GRALGRAIL, Inc. Common Stock | D | A | C | $59.98 |
About
YD Bio Ltd develops blood-based cancer detection technologies and stem cell and exosome-based therapeutics targeting high unmet medical needs in tissue regeneration and immune disorders. The company also supplies clinical testing drugs for pharmaceutical partners. Its platform addresses degenerative diseases and offers potential applications in personalized medicine.